The Week In... Pharma (06-10/04)

COVID-19: AstraZeneca and GSK work together to boost UK testing capacity, Boehringer Ingelheim to implement its global support programme, Roche receives US government funding to step up its Acterma testing, and there’s advice on steps to strengthen UK drug supply.

Britain will have a new coronavirus testing facility capable of carrying out 30,000 tests per day by early May, said the chief executive of pharma company AstraZeneca, helping the government meet an ambitious goal to scale up testing.

Boehringer Ingelheim has significantly stepped up its support to the fight against Covid-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine donations to healthcare institutions and communities in need around the world.

Dr Sam Roscoe explains his recommendations for pharmaceutical companies and supermarkets in the UK to limit reliance on deliveries from overseas, to ease the impact of the COVID-19 coronavirus on drug supply chains.